Search research articles
Contact Us
Filters
Showing results (31-40 of 107) with videos related to
Page
of 11
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 15, 2014
Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5)
Günter Emons, Grigor Gorchev, Philipp Harter, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
January 16, 2013
Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome(R) system 11G/8G vs. ATEC(R) system 12G/9G
Berndt-Michael Order, Philipp J Schaefer, G Peters, et al.
Histopathology
|
September 17, 2013
Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review
Stefan Kommoss, Cyril Blake Gilks, Friedrich Kommoss, et al.
The Lancet. Oncology
|
March 9, 2016
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
Christina H Ruhlmann, Thomas Broe Christensen, Line Hammer Dohn, et al.
Translational Oncology
|
June 5, 2013
Evaluation of potentially predictive markers for anti-angiogenic therapy with sunitinib in recurrent ovarian cancer patients
Dirk O Bauerschlag, Felix Hilpert, Werner Meier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 16, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary
Rosalind M Glasspool, Antonio González Martín, David Millan, et al.
Anticancer Research
|
May 27, 2004
Electrofusion generates diverse DC-tumour cell hybrids for cancer immunotherapy
Jan B Weise, Felix Hilpert, Axel Heiser, et al.
Cancer Letters
|
July 11, 2012
Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals
Inke Lühr, Andreas Friedl, Thorsten Overath, et al.
International Journal of Cancer
|
December 11, 2012
High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells
Juliane Volkmann, Ute Reuning, Martina Rudelius, et al.
Physical Chemistry Chemical Physics : PCCP
|
June 5, 2025
How the ionic liquid [C<sub>2</sub>C<sub>1</sub>Im][OTf] affects the stability of Pt(111) during potential cycling
Felix Hilpert, Yunsheng Qiu, Leopold Lahn, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 107) with videos related to
Sort By:
Page
of 11
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 15, 2014
Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5)
Günter Emons, Grigor Gorchev, Philipp Harter, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
January 16, 2013
Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome(R) system 11G/8G vs. ATEC(R) system 12G/9G
Berndt-Michael Order, Philipp J Schaefer, G Peters, et al.
Histopathology
|
September 17, 2013
Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review
Stefan Kommoss, Cyril Blake Gilks, Friedrich Kommoss, et al.
The Lancet. Oncology
|
March 9, 2016
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
Christina H Ruhlmann, Thomas Broe Christensen, Line Hammer Dohn, et al.
Translational Oncology
|
June 5, 2013
Evaluation of potentially predictive markers for anti-angiogenic therapy with sunitinib in recurrent ovarian cancer patients
Dirk O Bauerschlag, Felix Hilpert, Werner Meier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 16, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary
Rosalind M Glasspool, Antonio González Martín, David Millan, et al.
Anticancer Research
|
May 27, 2004
Electrofusion generates diverse DC-tumour cell hybrids for cancer immunotherapy
Jan B Weise, Felix Hilpert, Axel Heiser, et al.
Cancer Letters
|
July 11, 2012
Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals
Inke Lühr, Andreas Friedl, Thorsten Overath, et al.
International Journal of Cancer
|
December 11, 2012
High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells
Juliane Volkmann, Ute Reuning, Martina Rudelius, et al.
Physical Chemistry Chemical Physics : PCCP
|
June 5, 2025
How the ionic liquid [C<sub>2</sub>C<sub>1</sub>Im][OTf] affects the stability of Pt(111) during potential cycling
Felix Hilpert, Yunsheng Qiu, Leopold Lahn, et al.
Page
of 11